Oct 02, 2019
AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue
Sep 18, 2019
AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue
Sep 16, 2019
Neovasc Announces Changes to its Board of Directors
Sep 13, 2019
Bitauto Announces Receipt of Preliminary Non-Binding "Going Private" Proposal
Sep 04, 2019
AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue
Aug 22, 2019
Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
Aug 21, 2019
AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue
Jul 17, 2019
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule, Resolving Last Remaining Outstanding Nasdaq Deficiency
Jul 10, 2019
AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue
Jun 28, 2019
Neovasc Announces Effective Date of Share Consolidation
Jun 26, 2019
VEON Announces Settlement of GTH Taxes, Approval of Mandatory Tender Offer and Comprehensive GTH Restructuring
Jun 04, 2019
Neovasc Inc. Reports Results of Annual General and Special Meeting of Shareholders and Provides Update on Neovasc Reducer(TM)
May 22, 2019
Amgen announces a recommended public cash offer to the shareholders of Nuevolution
May 16, 2019
Neovasc Announces Closing of Private Placement of Convertible Debt and Common Shares for Gross Proceeds of US$11.5 Million
May 14, 2019
Neovasc Announces Private Placement of Convertible Debt and Equity for Gross Proceeds of US$11.5 Million
May 05, 2019
Statement from Garda World Security Corporation ("GardaWorld") - No intention to make an offer for G4S plc ("G4S" or the "Company")
Mar 12, 2019
Neovasc Announces Proposed Public Offering of Common Shares
Mar 12, 2019
Neovasc Announces Agreements to Exchange Outstanding Warrants for Shares
Jan 22, 2019
Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences
Jan 14, 2019
Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency